Vivarelli et al. demonstrated the influence of overexpressing survivin in Non-Hodgkin’s lymphoma (NHL) cancer patients, showing that high survivin levels were correlated with poor prognosis [109]. Here, BIRC5 is linked to non-Hodgkin lymphoma.